Doug Folsom, TRIMEDX
Doug Folsom, TRIMEDX
Soapbox

The Evolution of Medical Device Cybersecurity Threats in the Wake of COVID-19

By Doug Folsom

The omicron variant of the coronavirus has made clear that the impact of the pandemic is far from over, particularly for health systems and hospitals. The ongoing need to limit close contact between providers and patients means technology will continue to play a key role, but with that increased reliance on technology comes the heightened exposure to cyber risks, as well.

Continue reading

Sinisa Belina, Amplexor
Sinisa Belina, Amplexor
Soapbox

Beyond Compliance: The Business Case for Smart, Real-Time Quality Monitoring in Life Sciences Manufacturing

By Siniša Belina

The pandemic put unprecedented pressure on drug and medical device production, underlining the growing challenge of monitoring, analyzing, reporting and acting on quality. It became clearer than ever before that the more fragmented processes become, the more critical it is that they can be assessed and managed for consistent quality. At the same time, innovative tools and best practices have emerged.

Continue reading